Lumibird S.A. (LBIRD.PA)
Lannion, FR
A global leader, Lumibird S.A. specializes in the development, manufacturing, and distribution of a wide array of laser technologies. Its sophisticated laser products are deployed worldwide across scientific, industrial, and medical sectors. The company's operations are divided into two key segments: Photonics and Medical. Within its Photonics division, Lumibird offers an extensive portfolio, including solid-state lasers, high-power laser diodes, fiber lasers, and related amplifiers and components. This segment also provides advanced photonics solutions for time-of-flight LiDAR, range-finding, and Doppler LiDAR systems for wind measurement. These offerings are critical for industrial and scientific advancements, defense and space operations, and diverse LiDAR sensing needs. Concurrently, the Medical division delivers comprehensive medical and ophthalmological solutions, encompassing everything from diagnosis to laser-based therapies. Established in 1970, Lumibird S.A. maintains its corporate headquarters in Lannion, France.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.13% | +4.08% | +24.65% | +19.11% | +38.14% | +26.42% | +82.31% | +81.57% | +72.24% | +612.64% | +408.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | -1 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Hardware, Equipment & Parts: +10.0%+8.8% Q4'25: +14.4% (vs Q4'23)
-
EPS growth Hardware, Equipment & Parts: +20.2%+138.5% ★ Q4'25: +33.3% (vs Q4'23)
-
FCF margin FCF growth · Hardware, Equipment & Parts: +27.1%+0.9% Q4'25: +6.1% (vs Q4'23)
-
EBIT margin Hardware, Equipment & Parts: +8.7%+10.8% ★ Q4'25: +12.5% (vs Q4'23)
-
ROIC Hardware, Equipment & Parts: +5.7%+6.3% ★ Q4'25: +15.2% (vs Q4'23)
-
Share dilution Hardware, Equipment & Parts: +0.0%+2.1% Q4'25: +1.9% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Hardware, Equipment & Parts: -0.70×3.30× Q4'25: 1.49× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 1999 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. |
Dec 2030 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
22.24M
est.
|
37.20M
est.
|
42.03M
est.
|
47.62M
est.
|
63.23M
est: 62.00M (+2.0%)
|
63.97M
est: 63.30M (+1.1%)
|
37.82M
est: 85.10M (-55.6%)
|
101.80M
est: 100.90M (+0.9%)
|
112.65M
est: 110.10M (+2.3%)
|
129.51M
est: 126.70M (+2.2%)
|
162.47M
est: 162.00M (+0.3%)
|
194.29M
est: 190.85M (+1.8%)
|
206.55M
est: 207.33M (-0.4%)
|
210.06M
est: 207.10M (+1.4%)
|
228.53M
est: 225.60M (+1.3%)
|
246.10M
239.75M – 252.45M
+9.1% YoY
|
267.03M
261.67M – 272.40M
+8.5% YoY
|
286.87M
284.46M – 289.28M
+7.4% YoY
|
291.50M
284.84M – 298.16M
+1.6% YoY
|
311.00M
303.89M – 318.11M
+6.7% YoY
|
| EBITDA |
3.47M
est.
|
-317.8K
est.
|
5.42M
est.
|
4.92M
est.
|
5.24M
est: 9.67M (-45.8%)
|
3.61M
est: 9.87M (-63.4%)
|
4.38M
est: 9.06M (-51.7%)
|
16.69M
est: 5.44M (+206.7%)
|
20.42M
est: 17.22M (+18.5%)
|
17.96M
est: 21.02M (-14.5%)
|
31.81M
est: 26.29M (+21.0%)
|
32.09M
est: 29.47M (+8.9%)
|
27.31M
est: 34.62M (-21.1%)
|
31.03M
est: 34.58M (-10.3%)
|
44.32M
est: 37.67M (+17.7%)
|
41.09M
40.03M – 42.15M
+9.1% YoY
|
44.59M
43.69M – 45.48M
+8.5% YoY
|
47.90M
47.49M – 48.30M
+7.4% YoY
|
48.67M
47.56M – 49.78M
+1.6% YoY
|
51.93M
50.74M – 53.11M
+6.7% YoY
|
| EBIT |
1.76M
est.
|
-2.01M
est.
|
3.84M
est.
|
3.40M
est.
|
2.27M
est: 4.92M (-54.0%)
|
3.14M
est: 5.02M (-37.6%)
|
3.38M
est: 6.26M (-46.0%)
|
11.50M
est: 3.29M (+250.0%)
|
12.23M
est: 12.64M (-3.3%)
|
8.58M
est: 12.92M (-33.6%)
|
19.87M
est: 16.16M (+22.9%)
|
17.78M
est: 18.12M (-1.9%)
|
11.64M
est: 18.18M (-36.0%)
|
12.79M
est: 18.16M (-29.6%)
|
24.67M
est: 19.78M (+24.7%)
|
21.58M
21.02M – 22.14M
+9.1% YoY
|
23.41M
22.94M – 23.88M
+8.5% YoY
|
25.15M
24.94M – 25.36M
+7.4% YoY
|
25.56M
24.98M – 26.14M
+1.6% YoY
|
27.27M
26.65M – 27.89M
+6.7% YoY
|
| Net Income |
-16.02M
est.
|
-1.84M
est.
|
3.28M
est.
|
2.38M
est.
|
2.13M
est: 3.94M (-46.1%)
|
646.0K
|
1.74M
est: 4.39M (-60.3%)
|
8.08M
est: 2.06M (+292.3%)
|
8.82M
est: 8.95M (-1.4%)
|
5.64M
est: 10.09M (-44.1%)
|
13.86M
est: 12.61M (+9.9%)
|
11.35M
est: 10.61M (+7.0%)
|
7.13M
est: 6.51M (+9.5%)
|
5.70M
est: 6.40M (-11.1%)
|
14.00M
est: 14.01M (-0.1%)
|
20.60M
17.47M – 23.51M
+47.1% YoY
|
26.30M
24.70M – 29.82M
+27.7% YoY
|
32.25M
31.37M – 33.29M
+22.6% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| SGA |
7.58M
est.
|
11.37M
est.
|
12.77M
est.
|
15.18M
est.
|
10.84M
est: 21.12M (-48.7%)
|
11.12M
est: 21.56M (-48.4%)
|
14.30M
est: 27.98M (-48.9%)
|
43.37M
est: 11.26M (+285.2%)
|
46.24M
est: 32.39M (+42.8%)
|
-13.95M
est: 38.96M (-135.8%)
|
72.77M
est: 48.73M (+49.3%)
|
88.28M
est: 54.63M (+61.6%)
|
92.72M
est: 75.09M (+23.5%)
|
96.58M
est: 75.01M (+28.8%)
|
—
est: 81.71M (-100.0%)
|
89.13M
86.83M – 91.43M
+9.1% YoY
|
96.71M
94.77M – 98.66M
+8.5% YoY
|
103.90M
103.02M – 104.77M
+7.4% YoY
|
105.57M
103.16M – 107.99M
+1.6% YoY
|
112.64M
110.06M – 115.21M
+6.7% YoY
|
| EPS |
-0.73
est.
|
0.75
est.
|
1.00
est.
|
0.69
est.
|
0.26
est: 0.18 (+45.2%)
|
0.07
|
0.11
est: 0.24 (-54.9%)
|
0.51
est: 0.45 (+14.6%)
|
0.52
est: 0.41 (+28.4%)
|
0.25
est: 0.23 (+6.5%)
|
0.62
est: 0.65 (-4.2%)
|
0.51
est: 0.45 (+14.6%)
|
0.32
est: 0.30 (+8.1%)
|
0.26
est: 0.29 (-8.8%)
|
0.62
est: 0.63 (-0.8%)
|
0.93
0.78 – 1.05
+48.3% YoY
|
1.21
1.10 – 1.33
+30.9% YoY
|
1.44
1.40 – 1.48
+18.6% YoY
|
—
— – —
-100.0% YoY
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 3/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-05 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-04 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap ETF DFIS | 0.01% | 525.7K | 0.39% |
| 2 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 18.8K | 0.30% |
| 3 | Avantis Responsible International Equity ETF AVSD | 0.01% | 27.3K | 0.23% |
| 4 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 217.1K | 0.22% |
| 5 | Dimensional - International Vector Equity ETF DXIV | 0.00% | 375.76 | 0.53% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 10.4K | 0.28% |
| 7 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | — | 0.24% |
| 8 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Marc Le Flohic | Chief Executive Officer & Chairman | 503.7K | — |
| Jean-Marc Gendre | Deputy General Director & Chief Executive Officer of Lumibird Medical | 247.0K | male |
| Aude Nomblot-Gourhand | Financial Director | — | female |
| Frederic Chiquet | Chief Corporate Social Responsibility Officer | — | male |
| Nicolas Ballif | Director of Human Resources | — | male |
| Nigel Holehouse | Program Director | — | male |
| Philippe Metivier | Director of Research & Development | — | male |
| Pierre-Franasois Chenevier | Deputy General Director & General Director of Photonics Division | — | male |
| Alexandre Billard | Director of the Photonics Division & Purchasing Director | — | male |
| Sonia Rutnam | Chief Transformation Officer | — | female |
| Andrew Moysey | Group Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LBIRD.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
